< Back to companies
Toku Eyes

Toku Eyes

San Diego, California, United States

Toku Eyes utilizes multi-modal artificial intelligence and retinal imaging to provide instant healthcare diagnostics and risk assessments. Their platform screens for preventable blindness, cardiovascular disease, and chronic kidney disease risks. Key products include BioAge for biological age determination and MyKidneyAI for diabetes-related kidney risk. Aimed at healthcare professionals, the technology enables early detection and personalized prognostics to improve patient outcomes through accessible, accurate medical analysis. Leveraging a large dataset of retinal images linked to medical records, Toku ensures high-quality standards compliant with ISO 13485, facilitating widespread adoption in clinical settings for better preventive care.

Share
Shareable draft
Get Involved in Toku Eyes

Company Info

Founded
2018
Website
tokueyes.com/usa/

Categories

AI / MLDiagnosticsOphthalmologyCardiovascular Disease

Disease Areas

Technologies

DiagnosticsPlatform
Only accessible to MedStartr community members. Join now

What do you think of Toku Eyes?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Toku Eyes
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free